0001178697 false Q3 --12-31 P2Y 0001178697 2022-01-01 2022-09-30 0001178697 2022-10-31 0001178697 2022-09-30 0001178697 2021-12-31 0001178697 2022-07-01 2022-09-30 0001178697 2021-07-01 2021-09-30 0001178697 2021-01-01 2021-09-30 0001178697 us-gaap:CommonStockMember 2022-06-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001178697 us-gaap:RetainedEarningsMember 2022-06-30 0001178697 2022-06-30 0001178697 us-gaap:CommonStockMember 2021-12-31 0001178697 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001178697 us-gaap:RetainedEarningsMember 2021-12-31 0001178697 us-gaap:CommonStockMember 2021-06-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001178697 us-gaap:RetainedEarningsMember 2021-06-30 0001178697 2021-06-30 0001178697 us-gaap:CommonStockMember 2020-12-31 0001178697 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001178697 us-gaap:RetainedEarningsMember 2020-12-31 0001178697 2020-12-31 0001178697 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001178697 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001178697 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001178697 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001178697 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001178697 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001178697 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001178697 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001178697 us-gaap:CommonStockMember 2022-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001178697 us-gaap:RetainedEarningsMember 2022-09-30 0001178697 us-gaap:CommonStockMember 2021-09-30 0001178697 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001178697 us-gaap:RetainedEarningsMember 2021-09-30 0001178697 2021-09-30 0001178697 2021-09-14 2021-09-15 0001178697 srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001178697 SONM:SmartPhonesMember 2022-07-01 2022-09-30 0001178697 SONM:SmartPhonesMember 2021-07-01 2021-09-30 0001178697 SONM:SmartPhonesMember 2022-01-01 2022-09-30 0001178697 SONM:SmartPhonesMember 2021-01-01 2021-09-30 0001178697 SONM:FeaturePhonesMember 2022-07-01 2022-09-30 0001178697 SONM:FeaturePhonesMember 2021-07-01 2021-09-30 0001178697 SONM:FeaturePhonesMember 2022-01-01 2022-09-30 0001178697 SONM:FeaturePhonesMember 2021-01-01 2021-09-30 0001178697 SONM:TabletsAndOtherMember 2022-07-01 2022-09-30 0001178697 SONM:TabletsAndOtherMember 2021-07-01 2021-09-30 0001178697 SONM:TabletsAndOtherMember 2022-01-01 2022-09-30 0001178697 SONM:TabletsAndOtherMember 2021-01-01 2021-09-30 0001178697 us-gaap:OtherAssetsMember 2022-09-30 0001178697 us-gaap:OtherAssetsMember 2021-12-31 0001178697 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-09-30 0001178697 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2022-09-30 0001178697 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2022-09-30 0001178697 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001178697 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001178697 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001178697 2022-07-31 0001178697 us-gaap:AccountingStandardsUpdate201602Member 2022-09-30 0001178697 2022-08-28 2022-08-31 0001178697 2022-08-30 2022-08-31 0001178697 SONM:AccountsPayableFinancingAgreementMember 2019-01-01 0001178697 srt:MinimumMember SONM:AccountsPayableFinancingAgreementMember 2022-01-01 2022-09-30 0001178697 srt:MaximumMember SONM:AccountsPayableFinancingAgreementMember 2022-01-01 2022-09-30 0001178697 srt:MaximumMember SONM:AccountsPayableFinancingAgreementMember 2022-09-30 0001178697 SONM:AccountsPayableFinancingAgreementMember 2022-09-30 0001178697 SONM:AccountsPayableFinancingAgreementMember 2021-12-31 0001178697 SONM:AJPHoldingCompanyLLCMember SONM:SubscriptionAgreementMember 2022-04-12 2022-04-13 0001178697 SONM:AJPHoldingCompanyLLCMember SONM:SubscriptionAgreementMember 2022-04-13 0001178697 SONM:AJPHoldingCompanyLLCMember SONM:SubscriptionAgreementMember SONM:FirstClosingMember 2022-07-11 2022-07-13 0001178697 SONM:AJPHoldingCompanyLLCMember SONM:SubscriptionAgreementMember SONM:SecondClosingMember 2022-08-07 2022-08-08 0001178697 SONM:AJPHoldingCompanyLLCMember SONM:SubscriptionAgreementMember 2022-01-01 2022-09-30 0001178697 SONM:ChiefFinancialOfficerAndPresidentMember 2022-07-11 2022-07-13 0001178697 SONM:ChiefFinancialOfficerAndPresidentMember 2022-01-01 2022-09-30 0001178697 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001178697 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001178697 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001178697 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001178697 us-gaap:SellingAndMarketingExpenseMember 2022-07-01 2022-09-30 0001178697 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001178697 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-09-30 0001178697 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001178697 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001178697 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001178697 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001178697 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001178697 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001178697 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001178697 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0001178697 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001178697 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001178697 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001178697 us-gaap:RestrictedStockUnitsRSUMember 2022-09-30 0001178697 srt:MaximumMember 2022-01-01 2022-09-30 0001178697 SONM:SharesSubjectToOptionsToPurchaseCommonStockMember 2022-07-01 2022-09-30 0001178697 SONM:SharesSubjectToOptionsToPurchaseCommonStockMember 2021-07-01 2021-09-30 0001178697 SONM:SharesSubjectToOptionsToPurchaseCommonStockMember 2022-01-01 2022-09-30 0001178697 SONM:SharesSubjectToOptionsToPurchaseCommonStockMember 2021-01-01 2021-09-30 0001178697 SONM:UnvestedRestrictedStockUnitsMember 2022-07-01 2022-09-30 0001178697 SONM:UnvestedRestrictedStockUnitsMember 2021-07-01 2021-09-30 0001178697 SONM:UnvestedRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001178697 SONM:UnvestedRestrictedStockUnitsMember 2021-01-01 2021-09-30 0001178697 SONM:SharesSubjectToWarrantsToPurchaseCommonStockMember 2022-07-01 2022-09-30 0001178697 SONM:SharesSubjectToWarrantsToPurchaseCommonStockMember 2021-07-01 2021-09-30 0001178697 SONM:SharesSubjectToWarrantsToPurchaseCommonStockMember 2022-01-01 2022-09-30 0001178697 SONM:SharesSubjectToWarrantsToPurchaseCommonStockMember 2021-01-01 2021-09-30 0001178697 country:US 2022-07-01 2022-09-30 0001178697 country:US 2021-07-01 2021-09-30 0001178697 country:US 2022-01-01 2022-09-30 0001178697 country:US 2021-01-01 2021-09-30 0001178697 SONM:CanadaAndLatinAmericaMember 2022-07-01 2022-09-30 0001178697 SONM:CanadaAndLatinAmericaMember 2021-07-01 2021-09-30 0001178697 SONM:CanadaAndLatinAmericaMember 2022-01-01 2022-09-30 0001178697 SONM:CanadaAndLatinAmericaMember 2021-01-01 2021-09-30 0001178697 SONM:EuropeAndMiddleEastMember 2022-07-01 2022-09-30 0001178697 SONM:EuropeAndMiddleEastMember 2021-07-01 2021-09-30 0001178697 SONM:EuropeAndMiddleEastMember 2022-01-01 2022-09-30 0001178697 SONM:EuropeAndMiddleEastMember 2021-01-01 2021-09-30 0001178697 srt:AsiaPacificMember 2022-07-01 2022-09-30 0001178697 srt:AsiaPacificMember 2021-07-01 2021-09-30 0001178697 srt:AsiaPacificMember 2022-01-01 2022-09-30 0001178697 srt:AsiaPacificMember 2021-01-01 2021-09-30 0001178697 us-gaap:ProductMember 2022-07-01 2022-09-30 0001178697 us-gaap:ProductMember 2021-07-01 2021-09-30 0001178697 us-gaap:ProductMember 2022-01-01 2022-09-30 0001178697 us-gaap:ProductMember 2021-01-01 2021-09-30 0001178697 us-gaap:ServiceMember 2022-07-01 2022-09-30 0001178697 us-gaap:ServiceMember 2021-07-01 2021-09-30 0001178697 us-gaap:ServiceMember 2022-01-01 2022-09-30 0001178697 us-gaap:ServiceMember 2021-01-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerAMember 2022-07-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerAMember 2021-07-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerAMember 2022-01-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerAMember 2021-01-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerBMember 2022-07-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerBMember 2021-07-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerBMember 2022-01-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerBMember 2021-01-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerCMember 2022-07-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerCMember 2021-07-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerCMember 2022-01-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:CustomerCMember 2021-01-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:ConsumerDMember 2022-07-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:ConsumerDMember 2021-07-01 2021-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:ConsumerDMember 2022-01-01 2022-09-30 0001178697 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SONM:ConsumerDMember 2021-01-01 2021-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SONM:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

FORM 10-Q

(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to ____________

Commission File Number: 001-38907

Sonim Technologies, Inc.

(Exact -name of -registrant as -specified in its -charter)

Delaware |  | 94-3336783
( State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

4445 Eastgate Mall, Suite 200,

San Diego, CA 92121

(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: (650) 378-8100

6500 River Place Boulevard, Bldg. 7, S#250,

Austin, TX 78730

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock par value $0.001 per share |  | SONM |  | The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☐ | Accelerated filer | ☐
Non-accelerated filer | ☒ | Smaller reporting company | ☒
Emerging growth company | ☒ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 31, 2022, the registrant had 40,837,203 shares of common stock, $0.001 par value per share, issued and outstanding.

Table of Contents

|  | Page
PART I. | FINANCIAL INFORMATION |
Item 1. | Financial Statements (Unaudited) |
| Unaudited Condensed Consolidated Balance Sheets | 1
| Unaudited Condensed Consolidated Statements of Operations | 2
| Unaudited Condensed Consolidated Statements of Stockholder’s Equity | 3
| Unaudited Condensed Consolidated Statements of Cash Flows | 4
| Notes to Unaudited Condensed Consolidated Financial Statements | 5
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 16
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 23
Item 4. | Controls and Procedures | 23
PART II. | OTHER INFORMATION | 24
Item 1. | Legal Proceedings | 24
Item 1A. | Risk Factors | 24
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 24
Item 3. | Defaults Upon Senior Securities | 24
Item 4. | Mine Safety Disclosures | 24
Item 5. | Other Information | 24
Item 6. | Exhibits | 25
Signatures |  | 26

i

SONIM TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2022 AND DECEMBER 31, 2021 (UNAUDITED)

(IN THOUSANDS OF U.S. DOLLARS EXCEPT SHARE AND

PER SHARE AMOUNTS)

|  | September 30, 2022 |  |  | December 31, 2021 |
Assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 15,474 |  |  | $ | 11,233 |
Accounts receivable, net |  |  | 16,286 |  |  |  | 10,803 |
Non-trade receivable |  |  | 890 |  |  |  | 2,255 |
Inventory |  |  | 4,090 |  |  |  | 5,544 |
Prepaid expenses and other current assets |  |  | 2,437 |  |  |  | 5,852 |
Total current assets |  |  | 39,177 |  |  |  | 35,687 |
Property and equipment, net |  |  | 286 |  |  |  | 534 |
Right-of-use assets |  |  | 204 |  |  |  | — |
Other assets |  |  | 6,344 |  |  |  | 4,869 |
Total assets |  | $ | 46,001 |  |  | $ | 41,090 |
Liabilities and stockholders’ equity |  |  |  |  |  |  |  |
Current portion of long-term debt |  | $ | 147 |  |  | $ | 148 |
Accounts payable |  |  | 12,435 |  |  |  | 9,473 |
Accrued expenses |  |  | 10,761 |  |  |  | 11,353 |
Current portion of lease liability |  |  | 204 |  |  |  | — |
Deferred revenue |  |  | 266 |  |  |  | 11 |
Total current liabilities |  |  | 23,813 |  |  |  | 20,985 |
Income tax payable |  |  | 1,480 |  |  |  | 1,409 |
Long-term debt, less current portion |  |  | 37 |  |  |  | 66 |
Total liabilities |  |  | 25,330 |  |  |  | 22,460 |
Commitments and contingencies (Note 10) |  |  | - |  |  |  | - |
Stockholders’ equity |  |  |  |  |  |  |  |
Common stock, $0.001 par value per share; 100,000,000 shares authorized: and 40,637,828 and 18,808,855 shares issued and outstanding at September 30, 2022, and December 31, 2021, respectively. |  |  | 41 |  |  |  | 19 |
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at September 30, 2022, and December 31, 2021, respectively. |  |  | — |  |  |  | — |
Additional paid-in capital |  |  | 269,459 |  |  |  | 253,416 |
Accumulated deficit |  |  | (248,829 | ) |  |  | (234,805 | )
Total stockholders’ equity |  |  | 20,671 |  |  |  | 18,630 |
Total liabilities and stockholders’ equity |  | $ | 46,001 |  |  | $ | 41,090 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

SONIM TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(IN THOUSANDS OF U.S. DOLLARS EXCEPT SHARE AND PER SHARE AMOUNTS)

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30 |  |  | September 30 |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Net revenues |  | $ | 20,497 |  |  | $ | 14,445 |  |  | $ | 45,710 |  |  | $ | 38,639 |
Cost of revenues |  |  | 17,181 |  |  |  | 12,661 |  |  |  | 38,019 |  |  |  | 31,738 |
Gross profit |  |  | 3,316 |  |  |  | 1,784 |  |  |  | 7,691 |  |  |  | 6,901 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development |  |  | (135 | ) |  |  | 5,492 |  |  |  | 6,754 |  |  |  | 13,826 |
Sales and marketing |  |  | 1,511 |  |  |  | 3,087 |  |  |  | 5,754 |  |  |  | 7,456 |
General and administrative |  |  | 3,633 |  |  |  | 2,961 |  |  |  | 7,623 |  |  |  | 7,602 |
Legal expenses |  |  | 236 |  |  |  | 967 |  |  |  | 791 |  |  |  | 4,276 |
Total operating expenses |  |  | 5,245 |  |  |  | 12,507 |  |  |  | 20,922 |  |  |  | 33,160 |
Loss from operations |  |  | (1,929 | ) |  |  | (10,723 | ) |  |  | (13,231 | ) |  |  | (26,259 | )
Interest expense |  |  | (22 | ) |  |  | — |  |  |  | (96 | ) |  |  | — |
Gain on termination of lease |  |  | 730 |  |  |  | — |  |  |  | 730 |  |  |  | — |
Loss on sale of assets |  |  | (130 | ) |  |  | — |  |  |  | (130 | ) |  |  | — |
Other income (expense), net |  |  | (185 | ) |  |  | (126 | ) |  |  | (117 | ) |  |  | (419 | )
Loss before income taxes |  |  | (1,536 | ) |  |  | (10,849 | ) |  |  | (12,844 | ) |  |  | (26,678 | )
Income tax expense |  |  | (72 | ) |  |  | (90 | ) |  |  | (201 | ) |  |  | (227 | )
Net loss |  | $ | (1,608 | ) |  | $ | (10,939 | ) |  | $ | (13,045 | ) |  | $ | (26,905 | )
Net loss per share, basic and diluted |  | $ | (0.04 | ) |  | $ | (1.31 | ) |  | $ | (0.52 | ) |  | $ | (3.72 | )
Weighted–average shares used in computing net loss per Share, basic and diluted* |  |  | 36,085,226 |  |  |  | 8,366,283 |  |  |  | 24,888,859 |  |  |  | 7,222,541 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

SONIM TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022, AND 2021 (UNAUDITED)

(IN THOUSANDS OF U.S. DOLLARS EXCEPT SHARE AMOUNTS)

For the Three Months Ended September 30, 2022 |  | Shares |  |  | Amount |  |  | Paid-in Capital |  |  | Accumulated Deficit |  |  | Stockholders’ Equity |
|  | Common stock |  |  | Additional |  |  |  |  |  | Total |
For the Three Months Ended September 30, 2022 |  | Shares |  |  | Amount |  |  | Paid-in Capital |  |  | Accumulated Deficit |  |  | Stockholders’ Equity |
Balance at July 1, 2022 |  |  | 19,340,560 |  |  | $ | 19 |  |  | $ | 254,213 |  |  | $ | (247,220 | ) |  | $ | 7,012 |
Issuance of common stock, net of issuance costs |  |  | 20,833,333 |  |  |  | 21 |  |  |  | 14,349 |  |  |  | — |  |  |  | 14,370 |
Issuance of common stock, compensation |  |  | 385,599 |  |  |  | 1 |  |  |  | 260 |  |  |  | — |  |  |  | 261 |
Net settlement of common stock upon release of RSU |  |  | 98,336 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Employee and nonemployee stock-based compensation |  |  | — |  |  |  | — |  |  |  | 637 |  |  |  | — |  |  |  | 637 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,608 | ) |  |  | (1,608 | )
Balance at September 30, 2022 |  |  | 40,657,828 |  |  | $ | 41 |  |  | $ | 269,459 |  |  | $ | (248,829 | ) |  | $ | 20,671 |

|  | Common Stock |  |  | Additional |  |  |  |  |  | Total |
For the Nine Months Ended September 30, 2022 |  | Shares |  |  | Amount |  |  | Paid-in Capital |  |  | Accumulated Deficit |  |  | Stockholders’ Equity |
Balance at January 1, 2022 |  |  | 18,808,885 |  |  | $ | 19 |  |  | $ | 253,416 |  |  | $ | (234,805 | ) |  | $ | 18,630 |
Issuance of common stock, net of issuance costs |  |  | 20,878,638 |  |  |  | 21 |  |  |  | 14,394 |  |  |  | — |  |  |  | 14,415 |
Issuance of common stock, compensation |  |  | 800,622 |  |  |  | 1 |  |  |  | 513 |  |  |  | — |  |  |  | 514 |
Adoption of ASC 842 – leases (See Note 5) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (978 | ) |  |  | (978 | )
Net settlement of common stock upon release of RSU |  |  | 169,683 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Employee and nonemployee stock-based compensation |  |  | — |  |  |  | — |  |  |  | 1,136 |  |  |  | — |  |  |  | 1,136 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (13,045 | ) |  |  | (13,045 | )
Balance at September 30, 2022 |  |  | 40,657,828 |  |  | $ | 41 |  |  | $ | 269,459 |  |  | $ | (248,829 | ) |  | $ | 20,671 |

|  | Common Stock |  |  | Additional |  |  |  |  |  | Total |
For the Three Months Ended September 30, 2021 |  | Shares* |  |  | Amount* |  |  | Paid-in Capital* |  |  | Accumulated Deficit |  |  | Stockholders’ Equity |
Balance at July 1, 2021 |  |  | 6,695,272 |  |  | $ | 7 |  |  | $ | 225,099 |  |  | $ | (212,144 | ) |  | $ | 12,962 |
Issuance of common stock, net of issuance costs |  |  | 2,555,788 |  |  |  | 2 |  |  |  | 10,335 |  |  |  | — |  |  |  | 10,337 |
Net settlement of common stock upon release of RSU |  |  | 2,149 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Common stock variance, reverse stock split |  |  | 29 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Employee and nonemployee stock-based compensation |  |  | — |  |  |  | — |  |  |  | 285 |  |  |  | — |  |  |  | 285 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (10,939 | ) |  |  | (10,939 | )
Balance at September 30, 2021 |  |  | 9,253,238 |  |  | $ | 9 |  |  | $ | 235,719 |  |  | $ | (223,083 | ) |  | $ | 12,645 |

|  | Common Stock |  |  | Additional |  |  |  |  |  | Total |
For the Nine Months Ended September 30, 2021, |  | Shares* |  |  | Amount* |  |  | Paid-in Capital* |  |  | Accumulated Deficit |  |  | Stockholders’ Equity |
Balance at January 1, 2021 |  |  | 6,631,039 |  |  | $ | 7 |  |  | $ | 224,581 |  |  | $ | (196,178 | ) |  | $ | 28,410 |
Beginning balance |  |  | 6,631,039 |  |  | $ | 7 |  |  | $ | 224,581 |  |  | $ | (196,178 | ) |  | $ | 28,410 |
Issuance of common stock upon exercise of stock options |  |  | 707 |  |  |  | — |  |  |  | 5 |  |  |  | — |  |  |  | 5 |
Issuance of common stock, net of issuance costs |  |  | 2,555,788 |  |  |  | 2 |  |  |  | 10,335 |  |  |  | — |  |  |  | 10,337 |
Issuance of common stock upon exercise of ESPP |  |  | 9,992 |  |  |  | — |  |  |  | 38 |  |  |  | — |  |  |  | 38 |
Net settlement of common stock upon release of RSU |  |  | 55,683 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Common stock variance, reverse stock split |  |  | 29 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Employee and nonemployee stock-based compensation |  |  | — |  |  |  | — |  |  |  | 760 |  |  |  | — |  |  |  | 760 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (26,905 | ) |  |  | (26,905 | )
Balance at September 30, 2021 |  |  | 9,253,238 |  |  | $ | 9 |  |  | $ | 235,719 |  |  | $ | (223,083 | ) |  | $ | 12,645 |
Ending balance |  |  | 9,253,238 |  |  | $ | 9 |  |  | $ | 235,719 |  |  | $ | (223,083 | ) |  | $ | 12,645 |

The accompanying notes are an integral part of these condensed consolidated financial statements.

* | Reflects the 1-for-10 reverse stock split that became effective on September 15, 2021. Refer to Note 1 – The Company and its Significant Accounting Policies for further information.

3

SONIM TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021 (UNAUDITED)

(IN THOUSANDS OF U.S. DOLLARS)

|  | 2022 |  |  | 2021 |
|  | Nine Months Ended |
|  | September 30 |
|  | 2022 |  |  | 2021 |
Cash flows from operating activities: |  |  |  |  |  |  |  |
Net loss |  | $ | (13,045 | ) |  | $ | (26,905 | )
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 555 |  |  |  | 1,631 |
Stock-based compensation |  |  | 1,136 |  |  |  | 760 |
Stock issued for services |  |  | 514 |  |  |  | — |
Amortization of lease liability |  |  | (561 | ) |  |  | — |
Loss on disposal of asset |  |  | 130 |  |  |  | 59 |
Deferred income taxes |  |  | — |  |  |  | (9 | )
Gain on termination of lease |  |  | (730 | ) |  |  | — |
Lease termination fee |  |  | (260 | ) |  |  | — |
Bad debt expense |  |  | 2 |  |  |  | 685 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable |  |  | (5,485 | ) |  |  | 669 |
Non-trade receivable |  |  | 1,365 |  |  |  | (2,392 | )
Inventory |  |  | 1,454 |  |  |  | 1,438 |
Prepaid expenses and other current assets |  |  | 3,415 |  |  |  | 589 |
Other assets |  |  | (1,465 | ) |  |  | (1,134 | )
Accounts payable |  |  | 2,962 |  |  |  | 3,648 |
Accrued expenses |  |  | (482 | ) |  |  | 248 |
Warranty liability |  |  | 32 |  |  |  | (234 | )
Deferred revenue |  |  | 255 |  |  |  | (5 | )
Income tax payable |  |  | 71 |  |  |  | 40 |
Net cash provided by (used in) operating activities |  |  | (10,139 | ) |  |  | (20,912 | )
Cash flows from investing activities: |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (6 | ) |  |  | (20 | )
Net cash used in investing activities |  |  | (6 | ) |  |  | (20 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |
Repayment of debt |  |  | (30 | ) |  |  | (111 | )
Proceeds from issuance of common stock, net of costs |  |  | 14,414 |  |  |  | 9,046 |
Proceeds from ESPP purchase of stock |  |  | — |  |  |  | 38 |
Proceeds from exercise of stock options |  |  | — |  |  |  | 5 |
Net cash provided by (used in) financing activities |  |  | 14,384 |  |  |  | 8,978 |
Net increase (decrease) in cash and cash equivalents |  |  | 4,241 |  |  |  | (11,954 | )
Cash and cash equivalents at beginning of period |  |  | 11,233 |  |  |  | 22,141 |
Cash and cash equivalents at end of period |  | $ | 15,474 |  |  | $ | 10,187 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |  |
Cash paid for interest |  | $ | 96 |  |  | $ | — |
Cash paid for income taxes |  | $ | 103 |  |  | $ | 45 |
Non-cash operating and financing activities: |  |  |  |  |  |  |  |
Issuance of common stock included in other assets |  |  | — |  |  | $ | 1,291 |
Shares issued for consulting services |  | $ | 261 |  |  | $ | — |
Shares issued under bonus plans |  | $ | 253 |  |  | $ | — |

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

SONIM TECHNOLOGIES, INC

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(In thousands of U.S. dollars except share and per share amounts or as otherwise disclosed)

NOTE 1 —The Company and its significant accounting policies

Description of Business —Sonim Technologies, Inc. (Nasdaq: SONM) was incorporated in the state of Delaware on August 5, 1999, and is headquartered in San Diego, California. The Company is a leading U.S. provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles.

On September 15, 2021, the Company effected a 1-for-10 stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock on that date. Additionally, the number of shares of the Company’s common stock subject to outstanding stock options and restricted stock units, the exercise price of all of its outstanding stock options, and the number of shares of common stock reserved for future issuance pursuant to its equity compensation plans were adjusted proportionately in connection with the Reverse Stock Split. The number of authorized shares of common stock under the Company’s Amended and Restated Certificate of Incorporation and the par value per share of its common stock were unchanged. All historical share and per share amounts presented herein have been adjusted retrospectively to reflect these changes.

Liquidity and Ability to Continue as a Going Concern – The Company’s condensed consolidated financial statements account for the continuation of our business as a going concern. The Company is subject to the risks and uncertainties associated with the development and release of new products. The Company’s principal sources of liquidity as of September 30, 2022, consist of existing cash and cash equivalents totaling $15,474. During the third quarter of 2022, the Company raised $17,500 by selling common stock to an investor (see Note 7), netting approximately $14,370 after costs. The Company had current assets of $39,177 and current liabilities of $23,813. The Company had a net loss for the three months ended September 30, 2022 of $1,608 and the company may need significant cash to expand their product line into the durable consumer market for research and development expenses and marketing. There are significant costs associated with new product development and there is a need for sales volume of the new model of our rugged product for the consumer market to produce cash for further growth. If the sales of the new product fall short of our expectations, then the Company may need additional cash to meet its growth objectives. This raises substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements.

To alleviate a potential lack of liquidity, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic or investment partners with greater resources or access to funds or through obtaining credit from government or financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

Basis of presentation and preparation

The Company uses the same accounting policies in preparing quarterly and annual financial statements. The condensed consolidated financial statements include the accounts of Sonim Technologies, Inc. and its wholly owned subsidiaries (collectively “Sonim” or the “Company”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these unaudited condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. Certain prior period amounts in the unaudited condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual audited consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the year ended December 31, 2021.

Out of period adjustment

During the three months ended September 30, 2022, the Company recorded an out of period adjustment of approximately $1.05 million related to software costs for the XP10 smartphone that were expensed as part of research and development expenses in the second quarter of 2022 and should have been capitalized. The impact of this adjustment is a $1.05 million decrease to research and development expenses in the third quarter of 2022. After the adjustment, research and development expenses for the nine months ending September 30, 2022 are correct and capitalized non-recurring engineering (NRE) costs that are included in other assets are correct as of September 30, 2022.

5

New accounting pronouncements:

Pronouncements adopted in 2022:

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), as amended, which requires lessees to recognize a liability associated with obligations to make payments under the terms of the arrangement in addition to a right-of-use asset representing the lessee’s right to use, or to control the use of the given asset assumed under the lease. The Company adopted ASC 842 on January 1, 2022. The adoption of ASC 842 resulted in the recording of right-of-use assets, lease liability, and the derecognition of deferred lease liabilities, with the offset to equity. Beginning in 2022, the Company records the amortization of the right-of-use assets, with a corresponding reduction in rent expense. These changes were not applied to periods prior to 2022 and make comparison of the Company’s consolidated financial statements between periods difficult or impossible because of the differences in accounting standards used. See Note 5 for further information.

NOTE 2 —Revenue recognition

The Company recognizes revenue primarily from the sale of products, which are primarily mobile phones, tablets, and related accessories, and the majority of the Company’s contracts include only one performance obligation, namely the delivery of product. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company also recognizes revenue from other contracts that may include a combination of products and non-recurring engineering (NRE) services or from the provision of solely NRE services. Where there is a combination of products and NRE services, the Company accounts for the promises as individual performance obligations if they are concluded as distinct. Performance obligations are considered distinct if they are both capable of being identified and distinct within the context of the contract. In determining whether performance obligations meet the criteria for being distinct, the Company considers a number of factors, such as the degree of interrelation and interdependence between obligations, and whether or not the good or service significantly modifies or transforms another good or service in the contract. During the three and nine month periods ended September 30, 2022, and 2021, the Company did not have any contracts in which the products and NRE services were concluded to be a single performance obligation. In certain cases, the Company may offer tiered pricing based on volumes purchased for specific products. To date, all tiered pricing provisions have fallen into observable ranges of pricing to existing customers, thus, not resulting in any material right which could be concluded as its own performance obligation. In addition, the Company does not offer material post-contract support services to its customers.

Net revenue for an individual contract is recognized at the related transaction price, which is the amount the Company expects to be entitled to in exchange for transferring the goods and/or services. The transaction price for product sales is calculated as the product selling price, net of variable consideration, which may include estimates for marketing development funds, sales incentives, and price protection and stock rotation rights. The Company records reductions to net revenues related to future product returns based on the Company’s expectations and historical experience. Typically, variable consideration does not need to be constrained as estimates are based on specific contract terms. However, the Company continues to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur. The transaction price for a contract with multiple performance obligations is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices for products are determined based on the prices charged to customers, which are directly observable. Standalone selling price of the professional services are mostly based on time and materials. The Company determines its estimates of variable consideration based on historical collection experience with similar payor classes, aged accounts receivable by payor class, terms of payment agreements, correspondence from payors related to revenue audits or reviews, the Company’s historical settlement activity of audited and reviewed claims and current economic conditions using the portfolio approach. Revenue is recognized only to the extent that it is probable that a significant reversal of the cumulative amount recognized will not occur in future periods.

Revenue is then recognized for each distinct performance obligation as control is transferred to the customer. Revenue attributable to hardware is recognized at the time control of the product transfers to the customer. Control is generally transferred when the Company has a present right to payment and title and the significant risks and rewards of ownership of products or services are transferred to its customers. For most of the Company’s revenue attributable to hardware, control transfers when products are shipped. Revenue attributable to professional services is recognized as the Company performs the professional services for the customer.

6

Disaggregation of revenue

The following table presents our net revenue disaggregated by product category:

Schedule of Net Revenue Disaggregate by Product Category

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30 |  |  | September 30 |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Smartphones |  | $ | 1,506 |  |  | $ | 2,800 |  |  | $ | 10,956 |  |  | $ | 11,115 |
Feature Phones |  |  | 4,779 |  |  |  | 11,396 |  |  |  | 19,618 |  |  |  | 25,735 |
Tablets / Other |  |  | 14,212 |  |  |  | 249 |  |  |  | 15,136 |  |  |  | 1,789 |
Revenue |  | $ | 20,497 |  |  | $ | 14,445 |  |  | $ | 45,710 |  |  | $ | 38,639 |

Smartphone sales were lower in the third quarter of 2022 as the Company discontinued production and sale of its legacy smartphone product in anticipation of the launch of its new smartphone products in the fourth quarter of 2022. In the third quarter, the Company recognized revenue for the first time from a new and incrementally profitable tablet product line, which it developed and manufactured as an ODM for a third party.

Shipping and handling costs

The Company has elected to account for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included in cost of revenues.

Distributor returns allowance

The Company records reductions to net revenues related to future distributor product returns based on the Company’s expectation. The Company had allowances for distributor product returns totaling approximately $67 and $300 as of September 30, 2022 and 2021.

Contract costs

Applying the practical expedient, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred when the amortization period of the assets that otherwise would have been recognized is one year or less. These costs are included in sales and marketing expenses.

The non-recurring costs associated with design and development of new products for technical approval, represent costs to fulfill a contract pursuant to ASC 340-40 Other Assets and Deferred Costs. Accordingly, the Company capitalizes these non-recurring engineering costs and amortizes such costs over the estimated period of time over which they are expected to be recovered, which is typically 4 years, the estimated life of a particular model phone.

The total capitalized costs to fulfill a contract is primarily associated with Company’s XP3plus, XP5plus, and XP10 phones. As of September 30, 2022, and December 31, 2021, the total costs to fulfill a contract included in other assets were $1,682 and $2,345, respectively.

Contract balances

The Company records accounts receivable when it has an unconditional right to consideration. Contract liabilities are recorded when cash payments are received or due in advance of performance. Contract liabilities consist of advance payments and deferred revenue, where the Company has unsatisfied performance obligations. Contract liabilities are presented as a component of deferred revenue on the condensed consolidated balance sheets. As of September 30, 2022 and December 31, 2021, the contract liabilities were $266 and $11, respectively.

NOTE 3 —Fair value measurement

The fair value measurements standard establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the standard are described below:

Level 1—Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

7

Level 2—Inputs to the valuation methodology include:

| ● | Quoted market prices for similar assets or liabilities in active markets;
| ● | Quoted prices for identical or similar assets or liabilities in inactive markets;
| ● | Inputs other than quoted prices that are observable for the asset or liability;
| ● | Inputs that are derived principally from or corroborated by observable market data by correlation or other means.

If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.

Level 3—Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The assets or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

The following is a description of the valuation methodologies used for assets and liabilities measured at fair value. There have been no changes in the methodologies used at September 30, 2022, and December 31, 2021.

Money market funds are classified within level 1 of the fair value hierarchy because they are valued using quoted market prices.

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

The following tables sets forth by level, within the fair value hierarchy, the Company’s assets at fair value:

Summary of Fair Value Assets and Liabilities

|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | September 30, 2022 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds * |  | $ | 1,501 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,501 |

|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | December 31, 2021 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Money market funds * |  | $ | 1,500 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,500 |

* | Included in cash and cash equivalents on the condensed consolidated balance sheets.

NOTE 4 —Significant Balance Sheet Components

Accounts Receivable consists of the following:

Schedule of Accounts Receivable

|  | September 30, 2022 |  |  | December 31, 2021 |
Trade receivables |  | $ | 16,399 |  |  | $ | 11,735 |
Allowance for doubtful accounts |  |  | (113 | ) |  |  | (932 | )
Accounts receivable, net |  |  | 16,286 |  |  |  | 10,803 |
Vendor non-trade receivables |  |  | 890 |  |  |  | 2,255 |
Total accounts receivable |  | $ | 17,176 |  |  | $ | 13,058 |

The Company has non-trade receivables from a manufacturing vendor resulting from the sale of components to this vendor who manufactures and assembles final products for the Company.

8

The Company analyzes the need for reserves for potential credit losses and records allowances for doubtful accounts when necessary. The Company had allowances for such losses totaling approximately $113 and $932 as of September 30, 2022 and December 31, 2021, respectively. In July 2022, the Company reached a settlement with a customer of a $912 trade receivable that was fully reserved for in the December 31, 2021 allowance for doubtful accounts. The Company received $91 in cash and the remaining receivable was written off to the allowance for doubtful accounts.

Inventory consists of the following:

Schedule of Inventory

|  | September 30, 2022 |  |  | December 31, 2021 |
Finished goods |  | $ | 3,582 |  |  | $ | 2,952 |
Raw materials |  |  | 91 |  |  |  | 1,986 |
Accessories |  |  | 417 |  |  |  | 606 |
Inventory, Net |  | $ | 4,090 |  |  | $ | 5,544 |

Distributor returns allowance

The Company records reductions to cost of revenues related to future distributor product returns based on the Company’s expectation. The Company had inventory related to distributor product returns totaling approximately $41 and $229 as of September 30, 2022 and December 31, 2021 respectively.

Other assets consisted of the following:

Schedule of Other Assets

|  | September 30, 2022 |  |  | December 31, 2021 |
Deferred NRE |  | $ | 3,949 |  |  | $ | 2,345 |
Advances to third party manufacturers |  |  | 2,000 |  |  |  | 2,000 |
Deposits |  |  | 317 |  |  |  | 431 |
Other |  |  | 68 |  |  |  | 93 |
Total Other Assets |  | $ | 6,334 |  |  | $ | 4,869 |

Accrued Expenses consisted of the following:

Schedule of Accrued Expenses

|  | September 30, 2022 |  |  | December 31, 2021 |
Customer allowances |  | $ | 3,557 |  |  | $ | 3,148 |
Employee-related liabilities |  |  | 1,591 |  |  |  | 1,893 |
Warranties |  |  | 868 |  |  |  | 836 |
Accrual for goods received not invoiced |  |  | 16 |  |  |  | 668 |
Contractual obligations |  |  | 1,155 |  |  |  | 1,035 |
Royalties |  |  | 1,048 |  |  |  | 1,210 |
Research and development |  |  | 2,080 |  |  |  | 1,158 |
Shipping |  |  | — |  |  |  | 157 |
Returns allowance |  |  | 64 |  |  |  | 390 |
Legal |  |  | 290 |  |  |  | 517 |
Other |  |  | 92 |  |  |  | 341 |
Accrued liabilities, current |  | $ | 10,761 |  |  | $ | 11,353 |

NOTE 5 —Leases

The Company adopted ASU 2016-02 on January 1, 2022. The Company elected to use “the effective date” method where the comparative reporting periods is unchanged from legacy US GAAP. The Company elected the package of practical expedients to not reassess the classifications of existing leases and to not reassess if initial direct costs qualify for capitalization. The Company identified and continued to classify six leases as operating leases at January 1, 2022. All of the Company’s leases are for office space. The Company has elected the practical expedient to not separate lease components from non-lease components for all leases.

9

At adoption of ASC 842, the Company determined the fair value of the lease liability for each of the four operating leases (excluding the short-term leases) as the net present value of future lease payments using the Company’s incremental borrowing rate of 8.5%. The incremental borrowing rate was determined by management as the interest rate that the Company would pay for a loan with a repayment stream that is the same as the lease payment stream and for a loan that is secured by the underlying lease assets. The Company determined that the incremental rate was 8.5% for all four leases at January 1, 2022. An ROU asset that represents the Company’s right to use the leased asset, was established at adoption for the same amount as the lease liability. Per ASC 842, ROU assets were reduced by $142 with the derecognition of deferred lease liabilities from December 31, 2021.

One of the Company’s ROU assets is part of an asset group that had indicators of impairment (sublease income that is significantly less than the head lease obligation) as of December 31, 2021 and accordingly subject to an impairment analysis under ASC 360 at that time. At December 31, 2021 the amount of leasehold improvements and other recorded assets related to the asset group were not significant and as a result no impairment was required prior to adoption of ASC 842; however, had the recorded assets of the group at December 31, 2021 been significant an impairment charge would have been required. Upon adoption of ASC 842 and the recording of the ROU asset within this asset group, the Company reassessed impairment under ASC 360. As a result of this assessment, it was determined that as of the adoption date the fair value of the asset group was less than the recorded carrying value upon adoption and an impairment related to the ROU asset of $978 was required. Since all impairment conditions and events were present at December 31, 2021 as well as the adoption date, the Company recognized the impairment of $978 as an adjustment to beginning of the year retained earnings upon the adoption date.

The Company entered into a sublease for the above property in September 2021 that had sublease income that was significantly less than the head lease payments. This sublease is for 13 months which, at the option of the subtenant, can be extended for 12 additional months. In determining the fair value of the ROU asset, the Company assumed that the subtenant will extend the lease because the sublease payments are less than market value. The Company determined that the fair value of the ROU asset as the sum of the sublease payments for the 25 months of the sublease. The Company is amortizing this ROU asset as sublease payments are received. On August 31, 2022, the Company entered into an agreement with the landlord to cancel the head lease for $260 in consideration paid by the Company to the landlord. On August 31, 2022 the Company derecognized the remaining lease liability and ROU asset. This resulted in a $730 gain on the termination of the lease. The sublease was terminated when the head lease was terminated.

The Company elected the practical expedient for short-term leases for two leases that had terms of one year or less. ROU assets and lease liabilities were not established for these two short-term leases and rent payments are recorded as rent expense.

On January 1, 2022 the Company began recording all lease payments as the payment of lease interest expense and a reduction of the lease liability for the four leases that are not short-term. ROU assets are amortized over the life of the Company’s lease. The following table shows the activity of the ROU assets and lease liability for the nine months ending on September 30, 2022:

Summary of Activity of ROU Assets and Lease Liability

|  | Lease Liability |
Balance, December 31, 2021 |  | $ | — |
Adoption of ASC 842 |  |  | 1,976 |
Derecognition on cancelation of lease |  |  | (1,211 | )
Principal payments |  |  | (561 | )
Balance, September 30, 2022 |  |  | 204 |
Less short-term portion |  |  | 204 |
Long term lease liability |  | $ | — |

|  | ROU Assets |
Balance, December 31, 2021 |  | $ | — |
Adoption of ASC 842 |  |  | 1,976 |
Derecognition of deferred rent liability |  |  | (142 | )
Impairment of ROU asset |  |  | (978 | )
Derecognition on cancelation of lease |  |  | (221 | )
Amortization |  |  | (431 | )
Balance, September 30, 2022 |  | $ | 204 |

10

Future minimum lease payments under noncancelable operating lease commitments are as follows as of September 30, 2022:

Schedule of Future Minimum Lease Payments under Noncancelable Operating Lease Commitments

Year Ending, December 31st, |  |  |
2022 |  | $ | 108 |
2023 |  |  | 99 |
2024 |  |  | — |
2025 |  |  | — |
Total undiscounted minimum lease commitments |  | $ | 207 |
Effect of discounting |  |  | (3 | )
Lease liabilities at September 30, 2022 |  | $ | 204 |

In connection with leases, for the nine months ended September 30, 2022, the Company recognized $431 for the amortization of ROU assets, $95 for interest expense on lease liabilities, and no rent expense that was included in Cost of Revenues. Variable lease payments, including reimbursements to the landlord for property taxes and operating expenses, of approximately $134 and short-term rent payments of $11 were included in rent expense for the nine months ended September 30, 2022, and were offset by $80 in sublease income. The Company does not have any lease extension or termination options on any lease. There are no residual value guarantees in any lease. The weighted average remaining lease term of the operating leases is approximately 0.5 years. The weighted average of the discount rate for both the discount rate used to calculate the lease liabilities and the remaining balance of the lease payments for each lease as of September 30, 2022 is 8.5%.

NOTE 6 —Long-Term Debt

In 2014 and 2017, the Company entered into agreements with one of its suppliers, whereby certain of its trade payables for royalties and royalty up-front payments were converted to payment plans. In December 2018, the Company amended its accounts payable financing agreements, effective January 1, 2019, which provides for the $736 outstanding balance to be paid in twenty equal quarterly installments. The amounts due under these agreements are paid in quarterly installments over periods from two to four years, with interest ranging up to 8%. Remaining balances are $184 and $214 at September 30, 2022 and December 31, 2021, respectively.

NOTE 7 —Stockholders Equity

On April 13, 2022, the Company entered into a subscription agreement (the “Subscription Agreement”) with AJP Holding Company, LLC (“AJP”) whereby, subject to the terms thereof, AJP agreed to purchase from the Company an aggregate of 20,833,333 shares of the Company’s common stock (the “Purchased Shares”) for a purchase price of $0.84 per share, for an aggregate purchase price of $17.5 million.

Pursuant to the terms and conditions set forth in the Subscription Agreement, the Purchased Shares were issued in two tranches: (i) 14,880,952 shares of the Company’s common stock (the “Initial Shares”) was issued in consideration for an aggregate purchase price of $12.5 million (“First Closing”) and (ii) 5,952,381 shares will be issued for an aggregate purchase of $5.0 million.

The first closing was completed on July 13, 2022 and the second closing was completed on August 8, 2022.

In connection with the closings, the Company incurred approximately $3,130 of expenses which was offset against the proceeds in the third quarter of 2022.

Upon completion of the transaction, AJP controlled approximately 52% of Sonim’s post-transaction outstanding common stock. The agreement with AJP will also include a transition of the management team and the Company’s Executive Vice President for Global Operations and Engineering, who was appointed as Chief Executive Officer, effective April 14, 2022. The CEO is affiliated with the investment group at AJP. The Company continued to use the historical basis of assets and liabilities following the transaction.

On July 13, 2022, Robert Tirva, the CFO and President of the Company, resigned and became eligible for $1 million in severance payments over 20 months, plus certain health insurance benefits, if he meets certain requirements. The severance costs were charged to expense as of the severance date. On September 30, 2022, approximately $1.2 million in severance costs that were triggered by the AJP transaction were included in accrued expenses. On July 13, 2022, the Company appointed Clay Crolius as Chief Financial Officer.

11

On July 13, 2022 two of the Company’s Board Members resigned and the remaining Board of Directors appointed three new Board Members, including a representative of AJP. On July 14, 2022 the Board of Directors appointed two additional Board Members including Peter Liu, the Company’s Chief Executive Officer.

NOTE 8 —Stock-based Compensation

Stock-based compensation expense for the three and nine months ended September 30, 2022, and 2021 is as follows:

Schedule of Stock-based Compensation Expense

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Cost of revenues |  | $ | 9 |  |  | $ | 16 |  |  | $ | 89 |  |  | $ | 48 |
Sales and marketing |  |  | 3 |  |  |  | 45 |  |  |  | 53 |  |  |  | 156 |
General and administrative |  |  | 622 |  |  |  | 189 |  |  |  | 1,230 |  |  |  | 426 |
Research and development |  |  | 3 |  |  |  | 35 |  |  |  | 18 |  |  |  | 130 |
Stock-based compensation expense |  | $ | 637 |  |  | $ | 285 |  |  | $ | 1,136 |  |  | $ | 760 |

Stock Options:

Stock option activity for the nine months ended September 30, 2022, is set forth in the table below and reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

Summary of Stock Option Activity

|  |  |  |  | Weighted average |  |  | Weighted average Remaining |  |  | Aggregate |
|  |  |  |  | exercise price |  |  | contractual life |  |  | Intrinsic |
|  | Options |  |  | per share |  |  | (in years) |  |  | Value* |
Outstanding at January 1, 2022 |  |  | 95,413 |  |  | $ | 40.00 |  |  |  | 6.73 |  |  | $ | 0 |
Options granted |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Options exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Options forfeited |  |  | (15,303 | ) |  | $ | 33.65 |  |  |  |  |  |  |  |  |
Options expired |  |  | (17,562 | ) |  | $ | 48.55 |  |  |  |  |  |  |  |  |
Outstanding at September 30, 2022 |  |  | 62,548 |  |  | $ | 39.15 |  |  |  | 5.64 |  |  | $ | 0 |
Exercisable at September 30, 2022 |  |  | 54,887 |  |  | $ | 39.92 |  |  |  | 5.42 |  |  | $ | 0 |

* | The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.

As of September 30, 2022, there was approximately $429 of unamortized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of approximately two years.

12

Restricted Stock Units:

Restricted stock units’ (“RSU”) activity for the nine months ended September 30, 2022, is set forth in the table below and reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

Summary of Outstanding RSU's

|  | RSUs |
Outstanding at January 1, 2022 |  |  | 347,110 |
Granted |  |  | 554,591 |
Released |  |  | (169,683 | )
Forfeited |  |  | (40,661 | )
Outstanding at September 30, 2022 |  |  | 691,355 |

NOTE 9 —Income Taxes

In determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date profit or loss, adjusted for discrete items arising in that quarter. The Company’s annual estimated effective tax rate differs from the U.S. federal statutory rate primarily as a result of state taxes, foreign taxes, and changes in the Company’s valuation allowance against its deferred tax assets. For the three months ended September 30, 2022, and 2021, the Company recorded provisions for income taxes of $72 and $90, respectively.

NOTE 10 —Commitments and Contingencies

The terms and conditions of applicable bylaws, certificates or articles of incorporation, agreements or applicable law may obligate Sonim under certain circumstances to indemnify its current and former directors, officers or employees, and underwriters, with respect to certain of the matters described below and Sonim has been advancing legal fees and costs to certain current and former directors, officers, employees and underwriters in connection with certain matters describe below.

Third Party Designer Commitments—The aggregate amount of noncancelable outsourced third-party designer services for our next generation phones as of September 30, 2022 and December 31, 2021, was approximately $1,250 and $6,460, respectively, and were related to the XP5plus and the XP10.

Purchase Commitments—The aggregate amount of noncancelable purchase orders as of September 30, 2022 and December 31, 2021, was approximately $9,400 and $5,663, respectively, and are related to the purchase of components of our devices.

Royalty Payments— The Company is required to pay per unit royalties to wireless essential patent holders and other providers of integrated technologies on mobile devices delivered, which, in aggregate, amount to less than 5% of net revenues associated with each unit and expire between 2022 and 2026. Royalty expense for the nine months ended September 30, 2022, and 2021 was $964 and $1,369, respectively and is included in Cost of Revenues. The Company may be required to pay additional royalties to additional patent holder and technology providers on future products.

13

Securities and Exchange Commission Formal Order of Private Investigation: In March 2020, the Company received a voluntary document request from the SEC San Francisco Regional office, and in August 2020, the Company was informed that the SEC Staff was conducting a formal investigation into events that occurred in 2018-2019. The Company has been cooperating in the SEC’s ongoing investigation. In October 2021, the Company and the SEC Staff began discussions regarding a potential resolution of the investigation. These discussions are ongoing. The Company is unable to predict the likely outcome of the investigation, including whether it can be resolved through settlement negotiations, or determine its potential impact, if any, on the Company.

Derivative litigation—On September 21, 2020, the Company, and certain of its current and former directors and officers were sued by a stockholder on behalf of our Company in a derivative action in the United States District Court for the District of Delaware, captioned Kusiak v. Plaschke, et al., Case No 20-cv-1270-MN (“Kusiak”). The Kusiak complaint was based largely on the same underlying factual allegations as the ’33 Act Federal Action. The Company filed a motion to dismiss the Kusiak derivative action based on plaintiff’s failure to make a litigation demand on Sonim’s directors. On February 1, 2021, plaintiff in Kusiak voluntarily dismissed the action without prejudice.

On February 1, 2021, the same plaintiffs’ lawyers in the Kusiak action filed a new derivative action in the United States District Court for the District of Delaware against the Company and certain of its current and former directors and officers, captioned Gupta v. Plaschke, et al., Case No. 1:21-cv-130-MN (“Gupta”). The allegations in the Gupta complaint are generally similar to those in the Kusiak action. On March 29, 2022, Judge Dawson granted Defendants’ motion to dismiss and gave the plaintiff 14 days to file an amended complaint. No amended complaint was filed and on April 14, 2022 the federal court dismissed the action with prejudice.

General litigation—The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these other matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

The results of any future litigation cannot be predicted with certainty and, regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management time and resources and other factors.

Indemnification—Under the terms of its agreements with wireless carriers and other partners, the Company has agreed to provide indemnification for intellectual property infringement claims related to Company’s product sold by them to their end customers. From time to time, the Company receives notices from these wireless carriers and other partners of a claim for infringement of intellectual property rights potentially related to their products. These infringement claims have been settled, dismissed, have not been further pursued by the customers, or are pending for further action by the Company.

Contingent severance obligations—The Company has agreements in place with certain key employees (Executive Severance Arrangements) guaranteeing severance payments under certain circumstances. Generally, in the event of termination by the Company without cause, termination due to death or disability, or resignation for good reason, the Company is obligated to the pay the employees in accordance to the terms of the agreements. On July 13, 2022, Robert Tirva, the CFO and President of the Company, resigned and became eligible for $1 million in severance payments, plus certain health insurance benefits, over 20 months if he meets certain requirements. The severance costs were charged to expense as of the severance date. On September 30, 2022, approximately $1.2 million in severance costs that were triggered by the AJP transaction were included in accrued expenses. On July 13, 2022, the Company appointed Clay Crolius as Chief Financial Officer.

The Board of Directors approved annual bonus payments to certain executives for the 2021 year in January 2022, and payments in cash and stock were made in January and February of 2022 to the executives.

14

NOTE 11 —Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and nine months ended:

Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (1,608 | ) |  | $ | (10,939 | ) |  | $ | (13,045 | ) |  | $ | (26,905 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average shares used in computing net loss per share, basic and diluted |  |  | 36,085,226 |  |  |  | 8,366,283 |  |  |  | 24,888,859 |  |  |  | 7,222,541 |
Net loss per share, basic and diluted |  | $ | (0.04 | ) |  | $ | (1.31 | ) |  | $ | (0.52 | ) |  | $ | (3.72 | )

The dilutive common shares that were excluded from the calculation of diluted net loss per share because their effect would have been antidilutive for the period are presented in the table below. The table also reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

Summary of Dilutive Common Shares were Excluded from Calculation of Diluted Net Loss Per Share

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Shares subject to options to purchase common stock |  |  | 62,548 |  |  |  | 106,644 |  |  |  | 62,548 |  |  |  | 106,644 |
Unvested restricted stock units |  |  | 691,355 |  |  |  | 176,877 |  |  |  | 691,355 |  |  |  | 176,877 |
Shares subject to warrants to purchase common Stock |  |  | 2 |  |  |  | - |  |  |  | 2 |  |  |  | - |
Total |  |  | 753,905 |  |  |  | 283,521 |  |  |  | 753,905 |  |  |  | 283,521 |

NOTE 12 —Segment and Geographic Information

The Company operates in one reporting segment. Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance. The Company’s chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level.

The following table summarizes the revenue by region based on ship-to destinations for the three and nine months ended:

Summary of Revenue by Region

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
U.S. |  | $ | 4,351 |  |  | $ | 11,786 |  |  | $ | 24,284 |  |  | $ | 28,524 |
Canada and Latin America |  |  | 1,855 |  |  |  | 1,105 |  |  |  | 6,132 |  |  |  | 8,220 |
Europe and Middle East |  |  | 266 |  |  |  | 605 |  |  |  | 1,159 |  |  |  | 932 |
Asia Pacific |  |  | 14,025 |  |  |  | 949 |  |  |  | 14,135 |  |  |  | 963 |
Total revenues |  | $ | 20,497 |  |  | $ | 14,445 |  |  | $ | 45,710 |  |  | $ | 38,639 |

The following table summarizes the composition of revenues for the three and nine months ended:

Schedule of Composition of Revenues

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Product Sales |  | $ | 20,497 |  |  | $ | 14,412 |  |  | $ | 45,684 |  |  | $ | 38,563 |
Services |  |  | 0 |  |  |  | 33 |  |  |  | 26 |  |  |  | 76 |
Total revenues |  | $ | 20,497 |  |  | $ | 14,445 |  |  | $ | 45,710 |  |  | $ | 38,639 |

Revenue from customers with concentration greater than 10% in the three and nine months ended September 30, 2022 and 2021 accounted for approximately the following percentages of total revenues:

Schedule of Percentage of Total Revenues

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Customer A |  |  | 68 | % |  |  | -* |  |  |  | 30 | % |  |  | -* |
Customer B |  |  | 16 | % |  |  | 21 | % |  |  | 30 | % |  |  | 27 | %
Customer C |  |  | -* |  |  |  | 28 | % |  |  | 11 | % |  |  | 13 | %
Customer D |  |  | -* |  |  |  | 25 | % |  |  | 10 | % |  |  | 24 | %

* | Customer revenue did not exceed 10% in the respective period.

NOTE 13 —Subsequent Events

On October 26, 2022, our stockholders approved an amendment to the Company’s amended and restated certificate of incorporation, as amended that would effect a reverse stock split whereby a number of outstanding shares of our common stock between and including two (2) and fifteen (15), such number consisting only of whole shares, will be combined into one share of our common stock. The effectiveness of the reverse stock split or the abandonment of the reverse stock split will be determined by the Board in its discretion. If the Board chooses to effect the reverse stock split, it will set the timing and specific ratio from the range approved by the stockholders.

15

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K, as amended, for the year ended December 31, 2021. Certain statements in this report may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations, including, but not limited to, statements regarding our business strategies, growth prospects, operating and financial performance, plans, estimates and projections. These statements are based on management’s current expectations and beliefs and on information currently available to us. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements, including but not limited to:

| ● | We are not in compliance with the listing standards of the Nasdaq Stock Market and as a result our common stock may become delisted;
| ● | We may not be able to continue to develop solutions to address user needs effectively, including our next generation products, which would materially adversely affect our liquidity and our ability to continue operations;
| ● | We have not been profitable in recent years and may not achieve or maintain profitability in the future;
| ● | We rely on our channel partners to generate a substantial majority of our revenues;
| ● | A small number of customers account for a significant portion of our revenue;
| ● | We are materially dependent on some customer relationships that are characterized by product award letters and the loss of such relationships could harm our business and operating results;
| ● | We continue to restructure and transform our business and there is no guarantee that our restructuring or transformation will be successful or achieve the desired results;
| ● | Our quarterly results may vary significantly from period to period;
| ● | We rely primarily on third-party contract manufacturers and partners;
| ● | If our products contain defects or errors, we could incur significant unexpected expenses, experience product returns and lost sales, experience product recalls, suffer damage to our brand and reputation, and be subject to product liability or other claims;

16

| ● | We are required to undergo a lengthy customization and certification process for each wireless carrier customer;
| ● | Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales;
| ● | We are dependent on the continued services and performance of a concentrated and limited group of senior management and other key personnel;
| ● | We face risks related to health epidemics, pandemics and other outbreaks, including the COVID-19 pandemic;
| ● | Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business;
| ● | If we are unable to successfully protect our intellectual property, our competitive position may be harmed;
| ● | Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products;
| ● | We have identified one material weakness in our internal control over financial reporting which, if not remediated, could result in material misstatements in our financial statements;

The above is not a complete list of factors or events that could cause actual results to differ from our expectations, and we cannot predict all of them. Although we believe that we have a reasonable basis for each forward-looking statement contained in this report, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. You should review the “Risk Factors” contained in Part I, Item 1A. of our Annual Report on Form 10-K, for the year ended December 31, 2021, and Part II, Item 1A of this Quarterly Report on Form 10-Q for a discussion of factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Quarterly Report on Form 10-Q. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Company Overview

We are a leading provider of rugged and consumer durable mobile devices including phones and accessories designed to provide extra protection for users that demand more durability in their work and everyday lives. We currently have device placements in the three largest wireless carriers in the United States - ATT, Verizon and T-Mobile – as well as the three largest wireless carriers in Canada – Bell, Telus and Rogers. While we primarily sell through the wireless carrier channel, we also sell through distribution channels in North America and Europe. Our devices and accessories connect users with voice, data, workflow and lifestyle applications that enhance the user experience while providing an extra level of protection. In the third quarter we expanded our product line to tablets targeted for the Asia market as we start to broaden our portfolio.

Factors Affecting Our Results of Operations

We believe that the growth and future success of our business depend on many factors. While these factors present significant opportunities for our business, they also pose important challenges that we must successfully address in order to improve our results of operations.

Research and Development

We believe that our performance is significantly dependent on the investments we make in research and development and that we must continue to develop and introduce innovative and high quality, new products on a two to three-year cycle. Our partnerships with ODMs are expected to enable us to shift between different types and numbers of devices under development without the need to adjust the size of our internal team.

While the hardware design of our devices is generally the same for all wireless carriers, each device must be configured to conform to the requirements of each wireless carrier’s network, resulting in higher development expenses as the number of wireless carriers we sell through increases. In addition to the design and configuration costs, each device must undergo a multi-month technical approval process at each carrier before it can be certified to be stocked at such carrier. The approval process for each device for each carrier has historically cost between $1-2 million. Prior to commencement of development of a product for certification, we generally do not receive any purchase orders or commitments. Following a carrier’s review of product concepts, we may receive a product award letter from that carrier to move forward with the development and certification process, at which time we may begin receiving advance purchase orders or commitments. Since the timing of when we seek technical approval with our wireless carriers tends to be cyclical in nature, quarter-over-quarter expenditures may vary significantly depending on the number of approvals in process during the quarter. If we fail to innovate and enhance our product offerings, our brand, market position and revenues may be adversely affected. If our research and development efforts are not successful, we will not recover these investments that we make.

17

New Customer Acquisitions

We are focused on expanding our portfolio to service not only enterprise and public sector customers, but individual consumers as well. We have invested, and expect to continue to invest, in our sales and marketing efforts to expand into the consumer space and drive new customer acquisitions. As a result, we expect our sales and marketing costs to increase as we expand our customer reach and further evolve the Sonim brand. Sales and marketing investments will often occur in advance of any sales benefits from these activities, and it may be difficult for us to determine if we are efficiently allocating our sales and marketing resources.

New Product Introduction and Seasonality

We have historically experienced lower net revenue in the quarters leading up to new product introductions, as the revenue decline of legacy products does not perfectly match the revenue ramp up of new products. New product introductions can significantly impact net revenue, gross profit and operating expenses. The timing of product introductions can also impact our net revenue as our wireless carrier customers prepare for a new product launch, and channel inventory of an older product often declines as the launch of a newer product approaches. Net revenue can also be affected when consumers and distributors anticipate a new product introduction. However, neither historical seasonal patterns nor historical patterns of product or service introductions should be considered reliable indicators of our future pattern of product or service introductions, future net sales or financial performance.

Recent Developments

Agreement with AJP Holding Company, LLC

On April 13, 2022, we entered into a Subscription Agreement (the “Subscription Agreement”) with AJP Holding Company, LLC , a Delaware limited liability company (“AJP”), pursuant to which AJP has agreed to purchase from Sonim an aggregate of 20,833,333 shares of our common stock for a purchase price of $17,500,000 (the “Purchased Shares”). Additionally, pursuant to the Subscription Agreement, on April 13, 2022, Peter Liu, who had served as Sonim’s Executive VP for Global Operations and Engineering since September 2010, was appointed Chief Executive Officer of Sonim.

Pursuant to the terms and conditions set forth in the Subscription Agreement, on July 13, 2022, 14,880,952 shares of our common stock (the “Initial Shares”) were issued in consideration for an aggregate purchase price of $12,500,000 (“First Closing”), of which 952,381 shares were issued to Mr. Liu. Concurrent with the First Closing, all members of our board of directors (the “Board”), other than two Continuing Directors (as defined in the Subscription Agreement) resigned and three new members were appointed by the remaining members of our Board. In connection with the First Closing, Robert Tirva, then Company’s Chief Financial Officer and President, resigned and is eligible for one million dollars in severance payments over the next twenty months. Additionally, on July 13, 2022, the Board appointed Clay Crolius as Chief Financial Officer of the Company.

Shortly thereafter, on July 14, 2022, the Board convened and expanded its size to seven directors having appointed two more members including one independent director.

The second closing pursuant to the Subscription Agreement was consummated on August 8, 2022. Accordingly, the Company issued 5,952,381 shares of common stock in consideration for an aggregate purchase price of $5,000,000, provided that 417,500 have been issued to two assignees of AJP.

Liquidity and Going Concern

The Company’s condensed consolidated financial statements account for the continuation of our business as a going concern. The Company is subject to the risks and uncertainties associated with the development and release of new products. The Company’s principal sources of liquidity as of September 30, 2022, consist of existing cash and cash equivalents totaling $15,474. The Company had a net loss for the three months ended September 30, 2022 of $1,608 and the company may need significant cash to expand their product line into the durable consumer market for research and development expenses and marketing. There are significant costs associated with new product development and there is a need for sales volume of the new model of our rugged product for the consumer market to produce cash for further growth. If the sales of the new product fall short of our expectations, then the Company may need additional cash to meet its growth objectives. This raises substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements.

18

To alleviate a potential lack of liquidity, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic or investment partners with greater resources or access to funds or through obtaining credit from government or financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

Beginning with the filing of our Form 10-K for the period ended December 31, 2021, we have been subject to limitations under the applicable rules of Form S-3, which constrained our ability to secure capital pursuant to our existing ATM program or other registered offerings pursuant to our effective Form S-3. These rules limit the size of primary securities offerings conducted by issuers with a public float of less than $75 million to no more than one-third of their public float in any 12-month period. As of October 31, 2022, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was approximately $9.5 million, which was calculated based on approximately 20,311,913 shares of our outstanding common stock held by non-affiliates at a price of $0.47 per share, the closing price of our common stock on October 10, 2022. As such, we will be restricted from selling more than $3.1 million of securities pursuant to a shelf registration statement in any twelve-month period, so long as the aggregate market value of our common stock held by non-affiliates is less than $75.0 million.

Next Generation Ruggedized Mobile Phones

During the three months ended September 30, 2022, we prioritized spending on research and development of our new products, including our 5G enabled smartphone. This device will utilize new processors for increased performance and provide expanded network support for additional and new carriers in the United States, as well as in Europe. They will also include new features and support usability requirements based on feedback from our current customers. We expect to launch the new smartphone in the fourth quarter of 2022.

Expansion into the Consumer Durable Space

The Company plans on expanding from its core market in ultra-rugged mobile devices into the larger and faster growing consumer durable 5G market. This strategy is expected to drive revenue growth and increase operating efficiency as we adapt our core competency in ruggedization into the consumer space.

Nasdaq Minimum Bid Price Delinquency and Reverse Stock Split

On February 16, 2022, we received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that, for the last 30 consecutive business days, the bid price for our common stock had closed below $1.00 per share, which is the minimum closing price required to maintain continued listing on the Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have been provided a period of 180 calendar days, or until August 15, 2022, in which to regain compliance. We requested and received an additional 180-day period to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of our common stock must be at least $1.00 per share for a minimum of ten consecutive business days during this 180-day period. We intend to actively monitor the closing bid price of our common stock and are evaluating available options to regain compliance with the Minimum Bid Requirement, including by effecting a reverse stock split. On October 26, 2022, our stockholders approved an amendment to the Company’s amended and restated certificate of incorporation, as amended that would effect a reverse stock split whereby a number of outstanding shares of our common stock between and including two (2) and fifteen (15), such number consisting only of whole shares, will be combined into one share of our common stock. The effectiveness of the reverse stock split or the abandonment of the reverse stock split will be determined by the Board in its discretion. If the Board chooses to effect the reverse stock split, it will set the timing and specific ratio from the range approved by the stockholders.

Results of Operations

The following tables present key components of our results of operations for the three and nine months ended September 30, 2022, compared to results for the same period in 2021:

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | Increase (Decrease) |  |  | % |  |  | 2022 |  |  | 2021 |  |  | Increase (Decrease) |  |  | % |
Net revenues |  | $ | 20,497 |  |  | $ | 14,445 |  |  | $ | 6,052 |  |  |  | 42 | % |  | $ | 45,710 |  |  | $ | 38,639 |  |  | $ | 7,071 |  |  |  | 18 | %
Cost of revenues |  |  | 17,181 |  |  |  | 12,661 |  |  |  | 4,520 |  |  |  | 36 | % |  |  | 38,019 |  |  |  | 31,738 |  |  |  | 6,281 |  |  |  | 20 | %
Gross profit |  |  | 3,316 |  |  |  | 1,784 |  |  |  | 1,532 |  |  |  | 86 | % |  |  | 7,691 |  |  |  | 6,901 |  |  |  | 790 |  |  |  | 11 | %
Operating expenses |  |  | 5,245 |  |  |  | 12,507 |  |  |  | (7,262 | ) |  |  | (58 | %) |  |  | 20,922 |  |  |  | 33,160 |  |  |  | (12,238 | ) |  |  | (37 | %)
Loss from operations |  |  | (1,929 | ) |  |  | (10,723 | ) |  |  | 8,794 |  |  |  | 82 | % |  |  | (13,231 | ) |  |  | (26,259 | ) |  |  | 13,028 |  |  |  | 50 | %
Interest and other expense, net |  |  | 393 |  |  |  | (126 | ) |  |  | 519 |  |  |  | 412 | % |  |  | 387 |  |  |  | (419 | ) |  |  | 806 |  |  |  | 192 | %
Loss before income taxes |  |  | (1,536 | ) |  |  | (10,849 | ) |  |  | 9,313 |  |  |  | 86 | % |  |  | (12,844 | ) |  |  | (26,678 | ) |  |  | 13,834 |  |  |  | 52 | %
Income tax expense |  |  | (72 | ) |  |  | (90 | ) |  |  | (18 | ) |  |  | (20 | %) |  |  | (201 | ) |  |  | (227 | ) |  |  | (26 | ) |  |  | 11 | %
Net loss |  | $ | (1,608 | ) |  | $ | (10,939 | ) |  | $ | 9,331 |  |  |  | 85 | % |  | $ | (13,045 | ) |  | $ | (26,905 | ) |  | $ | 13,860 |  |  |  | 52 | %

Net Revenues

For the three months ended September 30, 2022, net revenues were at $20.5 million, as compared to $14.4 million for the three months ended September 30, 2021. Approximately 68% of net revenues for the third quarter of 2022 were from tablets that were developed specifically for a customer. When our new smartphone launches in the fourth quarter, we expect the percentage of revenue from tablets to decrease.

Smartphone sales were lower in the third quarter of 2022 as the Company discontinued production and sale of its legacy smartphone product in anticipation of the launch of its new smartphone products in the fourth quarter of 2022. As a strategy to diversify our product offering and to lower business risk, we are leveraging our experience and competency in North American carrier certification and design capability and we developed and manufactured a tablet product as an ODM for a third party, which we deliver in Asia. The product is imported and sold into a major US carrier by our customer. In the third quarter, the Company recognized revenue for the tablet product line, and will continue the ODM business in parallel to our effort of expending our rugged cell phone business into the consumer durable market.

For the nine months ended September 30, 2022, net revenues were $45.7 million compared to net revenues of $38.6 million for the nine months ended September 30, 2021, an increase of $7.1 million, or 18%. The increase was due to new tablet sales in the third quarter of 2022.

Our customer agreements with channel partners set forth the terms pursuant to which our channel partners purchase our products for distribution on a purchase order basis. While these arrangements are typically long term, they generally do not contain any firm purchase volume commitments. As a result, our channel partners are not currently contractually obligated to purchase from us any minimum number of products. The lack of firm purchase volume commitments makes it difficult for us to forecast customer demand. While our channel partners provide us with demand forecasts under these sales arrangements, we are generally required to satisfy any and all purchase orders delivered to us within specified delivery windows, with limited exceptions (such as orders significantly in excess of forecasts). Our sales arrangements also generally include technical performance standards for our mobile phones and accessories sold, which vary by channel partner. If a technical issue with any of our covered products exceeds certain preset failure thresholds for the relevant performance standards, the channel partner typically has the right to cease selling the product, cancel open purchase orders and levy certain monetary penalties. In addition, our channel partners retain sole discretion in which of their stocked products to offer their customers.

19

Gross Profit

Gross profit for the three months ended September 30, 2022, was $3.3 million, as compared to $1.8 million for the three months ended September 30, 2021, an increase of $1.5 million or 86%. The increase in gross profit is a result of revenue volume growth in 2022 driven by new tablet sales.

Gross profit for the nine months ended September 30, 2022, was $7.7 million, as compared to $6.9 million for the nine months ended September 30, 2021, an increase of $0.8 million or 11%. Higher tablet sales increased gross profit, but lower gross margin percentages on the tablets decreased the overall gross margin percentage in 2022.

Operating Expenses and Loss from Operations

Loss from operations for the three months ended September 30, 2022, was $1.9 million, as compared to $10.7 million for the three months ended September 30, 2021, an improvement of $8.8 million. This improvement was driven by a $5.6 million decrease in R&D because there was an out of period adjustment that decreased R&D by $1.0 million in 2022 and development projects were near completion in 2022 and software and testing costs were capitalized in 2022 instead of being expensed as R&D. Also, a $1.5 million improvement in gross profit combined with a $1.5 million decrease in sales and marketing expenses due to cost cutting in 2022 lowered operating expenses.

Loss from operations for the nine months ended September 30, 2022, was $13.2 million, as compared to $26.3 million for the nine months ended September 30, 2021, an improvement of $13.1 million. This improvement was driven by a decrease in operating expenses of $12.2 million, and a $0.8 million improvement in gross profit.

Operating expenses are summarized as follows:

|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | Change |  |  | % Change |  |  | 2022 |  |  | 2021 |  |  | Change |  |  | % Change |
|  | (in thousands, except %) |  |  | (in thousands, except %) |
Research and development expense |  | $ | (135 | ) |  | $ | 5,492 |  |  | $ | (5,627 | ) |  |  | (102 | %) |  | $ | 6,754 |  |  | $ | 13,827 |  |  | $ | (7,073 | ) |  |  | (51 | %)
Sales and marketing expense |  |  | 1,511 |  |  |  | 3,087 |  |  |  | (1,576 | ) |  |  | (51 | %) |  |  | 5,754 |  |  |  | 7,454 |  |  |  | (1,700 | ) |  |  | (23 | %)
General and administrative expense |  |  | 3,633 |  |  |  | 2,961 |  |  |  | 672 |  |  |  | 23 | % |  |  | 7,623 |  |  |  | 7,603 |  |  |  | 20 |  |  |  | 0 | %
Legal expense |  |  | 236 |  |  |  | 967 |  |  |  | (731 | ) |  |  | (76 | %) |  |  | 791 |  |  |  | 4,276 |  |  |  | (3,485 | ) |  |  | (82 | %)
Total Operating Expenses |  | $ | 5,245 |  |  | $ | 12,507 |  |  | $ | (7,262 | ) |  |  | (58 | %) |  | $ | 20,922 |  |  | $ | 33,160 |  |  | $ | (12,238 | ) |  |  | (37 | %)

Research and Development.

Research and development expenses for the three months ended September 30, 2022, were $(0.1) million, as compared to $5.5 million for the three months ended September 30, 2021, a decrease of $5.6 million, or 102%. The negative expense was due to an out of period adjustment as $1.05 million in software costs that should have been capitalized in the second quarter of 2022 were capitalized in the third quarter of 2022 resulting in a decrease to research and development costs of $1.05 million in the third quarter of 2022. Without this adjustment, research and development costs in the third quarter would have been $0.9 million. The decrease from $5.6 million in the prior year was because development projects were near completion in 2022 and software and testing costs were capitalized in 2022 instead of being expensed as R&D. In addition, there were headcount reductions at both Sonim and outsourced operations of $1.2 million and development costs were down $2.1 million, driven by a surge in 2021 for the XP3Plus feature phone, that was launched at the end of the quarter.

Research and development expenses for the nine months ended September 30, 2022, were $6.8 million, as compared to $13.8 million for the nine months ended September 30, 2021, a decrease of $7.1 million, or 51%. These expenses decreased primarily because development projects were closer to completion in 2022 and software and testing costs were capitalized in 2022. R&D expenses also decreased due to headcount reductions at both Sonim and outsourced operations of $2.8 million and $1.1 million.

Sales and Marketing.

Sales and marketing expenses for the three months ended September 30, 2022, were $1.5 million, as compared to $3.1 million for the three months ended September 30, 2021, a decrease of $1.6 million, or 51%. These expenses decreased due to a $0.7 million decrease in employee headcount related costs and higher new product demo units for the XP3Plus launch in 2021 of $0.9 million.

Sales and marketing expenses for the nine months ended September 30, 2022, were $5.8 million, as compared to $7.5 million for the nine months ended September 30, 2021, a decrease of $1.7 million, or 23%. These expenses decreased due to a $0.8 million reduction in employee headcount related costs and new product demo units for the XP3Plus launch in 2021 of $ 0.9 million

20

General and Administrative.

General and administrative expenses for the three months ended September 30, 2022, were $3.6 million, as compared to $3.0 million for the three months ended September 30, 2021, an increase of $0.7 million, or 26%. This increase was driven by $1.2 million severance accruals and $0.4 million for the acceleration of RSU vesting triggered by a change of control as a result of the AJP investment.

General and administrative expenses for the nine months ended September 30, 2022, were $7.6 million, as compared to $7.6 million for the nine months ended September 30, 2021, an increase of $0.02 million, or .3%. Severance accruals of $1.2 million and the acceleration of RSU vesting of $0.4 million due to the change in control, were partially offset by headcount related savings.

Legal expenses.

Legal expenses for the three months ended September 30, 2022, were $0.2 million, as compared to $1.0 million for the three months ended September 30, 2021, a decrease of $0.7 million, or 82%. The decrease of $0.7 million in these expenses was primarily because there was less activity in 2022 on the SEC matter, which was $.7 million in 2021.

Legal expenses for the nine months ended September 30, 2022, were $0.8 million, as compared to $4.3 million for the nine months ended September 30, 2021, a decrease of $3.5 million, or 83%. Legal expenses were higher for the nine months ended September 30, 2021, due to the costs related to the SEC matter of $3.5 million.

Interest and Other Expense, net

Interest and other expenses decreased by $0.5 million for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. This decrease was primarily due to a gain on a lease termination of $0.7 million, offset partially by exchange rates of $0.2 million and a loss on the sale of an asset of $0.1 million.

Interest and other expenses decreased by $0.8 million for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. This decrease was primarily due to gain on a lease termination of $0.7 million and a benefit from exchange rates $0.3 million, offset partially by the loss on the sale of fixed asset of $0.1 million.

Income Tax Expense

Income tax expense was $0.1 million for the three months ended on September 30, 2022 and $0.2 million for the three months ended September 30, 2021. Due to ongoing losses the Company pays little income tax.

Income tax expense was $0.2 million for the nine month ended on September 30, 2022 and 2021. Due to ongoing losses the Company pays little income tax.

Liquidity and Capital Resources (dollars in thousands other than per share amounts)

The Company’s condensed consolidated financial statements account for the continuation of our business as a going concern. The Company is subject to the risks and uncertainties associated with the development and release of new products. The Company’s principal sources of liquidity as of September 30, 2022, consist of existing cash and cash equivalents totaling $15,474. The Company had current assets of $39,177 and current liabilities of $23,813. The Company had a net loss for the three months ended September 30, 2022 of $1,608 and the company may need significant cash to expand their product line into the durable consumer market for research and development expenses and marketing. There are significant costs associated with new product development and there is a need for sales volume of the new model of our rugged product for the consumer market to produce cash for further growth. If the sales of the new product fall short of our expectations, then the Company may need additional cash to meet its growth objectives. This raises substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these condensed consolidated financial statements.

To alleviate a potential lack of liquidity, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic or investment partners with greater resources or access to funds or through obtaining credit from government or financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

21

Summary of Cash Flows

Cash and cash equivalents as of September 30, 2022, was $15.0 million, or $4.8 million higher than cash and cash equivalents of $10.2 million on September 30, 2021. The increase was from the net proceeds from the issuance of stock to an investor of $14.4 million, partially offset by operating losses.

The following table summarizes our sources and uses of cash for the periods presented:

|  | Nine ended September 30, |
(in thousands) |  | 2022 |  |  | 2021 |
Net cash used in operating activities |  | $ | (10,139 | ) |  | $ | (20,912 | )
Net cash used in investing activities |  |  | (6 | ) |  |  | (20 | )
Net cash provided by financing activities |  |  | 14,384 |  |  |  | 8,978 |
Net increase (decrease) in cash and cash equivalents |  |  | 4,241 |  |  |  | (11,954 | )

Cash flows from operating activities

For the nine months ended September 30, 2022, cash used in operating activities was $10. million. The negative cash flow was primarily due to a net loss of $13.0 million and an increase in accounts receivable of $5.5 million due to large billings at quarter end. These uses were partially offset by lower prepaids of $3.4 million, higher accounts payable of $3.0 million, and lower inventory of $1.5 million.

For the nine months ended September 30, 2021, cash used in operating activities was $20.9 million, primarily attributable to a net loss of $26.9 million and by changes in our non-trade receivables of $2.4 million and other assets of $1.1 million. These were partially offset by an increase to accounts payable of $3.6 million, $1.6 million in depreciation and amortization, and $0.8 million in stock-based compensation expense.

Cash flows from investing activities

For the nine months ended September 30, 2022 and September 30, 2021, there were no significant investing activities.

Cash flows from financing activities

For the nine months ended September 30, 2022, cash provided by financing activities was $14.4 million due to amounts received from AJP of $17.5 million, less $3.1 million in costs (see Note 7). The first closing of the subscription agreement was completed on July 13, 2022 and the second closing was completed on August 8, 2022.

For the nine months ended September 30, 2021, cash provided by financing activities was $9.0 million, as a result the issuance of common stock.

Material Cash Requirements

There have been no material changes to our material cash requirements from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.

Critical Accounting Estimates

The preparation of these unaudited consolidated financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material.

Recently Issued Accounting Pronouncements

See Note 1 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently issued accounting pronouncements.

Segment Information

We have one business activity and operate in one reportable segment.

22

JOBS Act

We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. We expect to use the extended transition period for any other new or revised accounting standards during the period in which we remain an emerging growth company. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the consummation of our IPO, (ii) the last day of the fiscal year in which we have total annual gross revenue of at least $1.235 billion, (iii) the last day of the fiscal year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Security Exchange Act of 1934, as amended (the “Exchange Act”),, which would occur if the market value of our common stock held by non-affiliates exceeded $700 million as of the last business day of the second fiscal quarter of such year, or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. Even after we no longer qualify as an emerging growth company, we may still qualify as a smaller reporting company, which would allow us to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our prospectuses and in our periodic reports and proxy statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act, prior to filing this Quarterly Report on Form 10-Q. Based on this evaluation, and as a result of the material weakness in our internal control over financial reporting described below, as well as a signature issue with the certifications of our management’s report on internal controls in our original Annual Report on Form 10-K for the year ended December 31, 2021, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were not effective at the reasonable assurance level.

Material Weaknesses in Internal Control and Plan for Remediation

As disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021, we previously identified a material weakness in our internal controls over financial reporting related to the design and implementation of our IT general controls including elevated (administrator) access to financial reporting systems and subsystems. As noted in our Form 10-Q for the quarter ended March 31, 2022, we improved our IT general controls by removing most elevated (administrator) access to financial reporting systems and by providing additional controls over administrator system access. We are making progress towards remediation of the material weakness.

Changes in Internal Control Over Financial Reporting

Except as otherwise disclosed, there was no change in our internal control over financial reporting that occurred during the three months ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

In reviewing the financial statements for the quarter ending September 30, 2022 we identified a significant internal control deficiency in how we identify software costs that should be capitalized rather than expensed. We implemented a new control where the Sonim engineering group notifies the Sonim finance group at the end of every quarter of any project that has achieved technological feasibility after which costs will be capitalized. This new control will be performed beginning in the fourth quarter of 2022. See related Out of Period Adjustment in Note 1.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating disclosure controls and procedures, our management recognizes that any system of controls, however well designed and operated, can provide only reasonable assurance, and not absolute assurance, that the desired control objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals in all future circumstances. Accordingly, our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met.

23

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

For information regarding our material legal proceedings, see “Note 10. Commitments and Contingencies” in the accompanying “Notes to Consolidated Financial Statements” in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

Item 1A. Risk Factors.

There are no material changes to the risk factors set forth in Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

24

Item 6. Exhibits.

Exhibit Number |  | Description |  | Form |  | File No. |  | Incorporated by Exhibit Reference |  | Filing Date
3.1 |  | Amended and Restated Certificate of Incorporation of the Registrant. |  | 8-K |  | 001-38907 |  | 3.1 |  | May 17, 2019
3.2 |  | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective September 15, 2021. |  | 8-K |  | 001-38907 |  | 3.1 |  | September 15, 2021
3.3 |  | Amended and Restated Bylaws of the Registrant. |  | 8-K |  | 001-38907 |  | 3.1 |  | November 8, 2021
10.1 |  | Purchaser Support Agreement, dated as of July 13, 2022, by and between the Company and AJP Holding Company, LLC. |  | 8-K |  | 001-38907 |  | 10.1 |  | July 13, 2022
10.2† |  | Designee Support Agreement, dated as of July 13, 2022, by and between the Company and Peter Liu |  | 8-K |  | 001-38907 |  | 10.2 |  | July 13, 2022
10.3† |  | Release Agreement with Robert Tirva, dated as of July 13, 2022. |  | 8-K |  | 001-38907 |  | 10.3 |  | July 13, 2022
10.4†# |  | Letter Agreement with Clay Crolius, dated as of July 13, 2022. |  | 8-K |  | 001-38907 |  | 10.4 |  | July 13, 2022
10.5 |  | Registration Rights Agreement, dated as of July 13, 2022, by and between the Company and AJP Holding Company, LLC |  | 8-K |  | 001-38907 |  | 10.5 |  | July 13, 2022
10.6† |  | Employment Agreement dated as of August 18, 2022, by and between Sonim Technologies, Inc. and Peter Hao Liu |  | 8-K |  | 001-38907 |  | 10.1 |  | August 23, 2022
31.1 |  | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |
31.2 |  | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |
32.1* |  | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |
32.2* |  | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  |  |  |  |  |
101.INS |  | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |  |  |  |  |  |  |  |
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document. |  |  |  |  |  |  |  |
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |  |  |  |  |  |  |  |
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document. |  |  |  |  |  |  |  |
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document. |  |  |  |  |  |  |  |
101PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |  |  |  |  |  |  |  |
104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  |  |  |  |  |  |  |

* | The certifications furnished in Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
† | Agreement with management or compensatory plan or arrangement.
# | Certain schedules, exhibits, and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| SONIM TECHNOLOGIES, INC.
Date: November 14, 2022 | By: | /s/ Hao Liu
|  | Hao (Peter) Liu
|  | Chief Executive Officer (Principal Executive Officer)

Date: November 14, 2022 | By: | /s/ Clayton Crolius
|  | Clayton Crolius
|  | Chief Financial Officer (Principal Financial and Accounting Officer)

26